CARDIOL THERAPEUTICS INC. (CRDL)
Clinical trial NCT02699957 updates: 1. completion date: 2026-01-01 → 2029-01-01 2. primary completion date: 2026-01-01 → 2029-01-01
Clinical trial NCT02699957 updates: 1. completion date: 2026-01-01 → 2029-01-01 2. primary completion date: 2026-01-01 → 2029-01-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical